Working… Menu

Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis (COBALT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02308111
Recruitment Status : Recruiting
First Posted : December 4, 2014
Last Update Posted : October 11, 2019
Information provided by (Responsible Party):
Intercept Pharmaceuticals